1,5-Dimethyl-1H-pyrazole-4-methanamine | CAS 400756-31-2

Element: methanamine dimethyl pyrazole

Page Content Identification Properties Suppliers Prices & Availability Get Quick Quote ☰

Identification Properties Suppliers Prices & Availability Get Quick Quote

C-S » Chemicals » dimethyl-pyrazole-methanamine-PX458879

Identification

1,5-Dimethyl-1H-pyrazole-4-methanamine

CAS:

400756-31-2

EINECS:

Molecular Formula:

C₆H₁₁N₃

MDL:

MFCD02055882

Synonym:

1h-pyrazole-4-methanamine, 1,5-dimethyl- ; 1,5-dimethyl-4-pyrazolemethanamine ; (1,5-dimethylpyrazol-4-yl)methylamine ; 1,5-dimethyl-(1h)-pyrazole-4-methanamine ; (1,5-dimethyl-4-pyrazolyl)methanamine ; (1,5-dimethylpyrazol-4-yl)methanamine ; (1,5-dimethyl-1h-pyrazol-4-yl)methanaminehydrochloride ; 1-(1,5-dimethyl-1h-pyrazol-4-yl)methanamine(saltdata: free)

Suppliers

Leap Chem Co., Ltd

LC20526156

Dayang Chem (Hangzhou) Co.,Ltd.

DC353414136

Get Quick Quote

CAS equal suppliers

(1,5-dimethyl-1H-pyrazol-4-yl)methylamine

Santa Cruz Biotechnology, Inc.

282370

Prices & Availability

Data is processed

Properties for 1,5-Dimethyl-1H-pyrazole-4-methanamine

Molecular Weight:

125.17 g·mol−1

Density:

1.12 ±0.1 g/cm3 (20 °C 760 Torr)

Boiling point:

233.2 ±25.0°C (760 Torr)

Flash point:

94.8 ±23.2°C

Hazard Statements

GHS03
Harmful

Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, categories 2, 3
Eye irritation, category 2A
Skin sensitization, category 1
Specific target organ toxicity following single exposure, category 3
- Respiratory tract irritation
- Narcotic effects

Not used

with the "skull and crossbones" pictogram
for skin or eye irritation if:
the "corrosion" pictogram also appears
the "health hazard" pictogram is used to indicate respiratory sensitization

Safety & Transport Information

Alternative Distributors of [1,5-Dimethyl-1H-pyrazole-4-methanamine]

Producers or manufacturers change the product range from time to time. The following companies
have appeared as suppliers in the past / currently not verified

Suzhou Rovathin Pharmatech Co., Ltd